Medical Marijuana Helps Treat Suicidal Thoughts And Depression, New Study
Stocks in Play: Organigram Holdings Inc.
Organigram Makes Partial Third Tranche Investment of $1M in Phylos Bioscience
Organigram Expands Cannabis Selection With Phylos Investment
Organigram Brief: Says O Bolster Auto-Flower and Rare Cannabinoid Portfolio With Partial Third Tranche Investment of US$1 Million Into Phylos
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio With Partial Third Tranche Investment of US $1M Into Phylos
US, Canadian Pot Firms Eye Germany for Growth as Market Stagnates at Home
Marijuana Stock Movers For July 22, 2024
Joe Biden Drops Out: What Would Happen With Cannabis Legalization Under Kamala Harris Or Donald Trump?
Marijuana Stock Movers For July 19, 2024
Express News | Canaccord Genuity Assumes OrganiGram Holdings at Speculative Buy, Announces Price Target of C$3.25
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Maintains Target Price $2.38
OrganiGram Holdings Switches Auditors Amidst Industry Shift
OrganiGram | 6-K: Report of foreign private issuer (related to financial reporting)
Marijuana Stock Movers For July 11, 2024
A $2 Billion Opportunity In Cannabis: How A Tobacco Giant Is Helping Organigram Seize The German Market
Marijuana Stock Movers For July 4, 2024
Cannabis Stock Gainers And Losers From July 3, 2024
Decibel's Dominance In Pre-Rolls Tested By Market Shifts And 16% Revenue Drop: What Investors Need To Know
Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
No Data